黄芪、生脉注射液治疗心律失常的临床疗效观察

目的观察黄芪和生脉注射液对轻型心律失常的临床疗效。方法将100例心律失常病人随机分为治疗组和对照组,全部病例均经静息心电图或24小时动态心电图证实有不同类型和程度的心律失常,在综和治疗的基础上,治疗组加用黄芪和生脉注射液,对照组加用倍他乐克、心律平、利多卡因等常规制剂。结果与对照组(总有效率72%)相比,治疗组(总有效率96%)对患者临床症状的改善及心律失常的疗效均优于对照组(P<0.05)。结论黄芪和生脉注射液对轻型的心律失常有较明显的治疗效果。

Objective ： to observe the clinical effect of huangqi and shengmai injection against moderate arrhythmia. Method： to divide 100 patients of arrhythmia into two groups known as treatment group and control group. All of the patients have been confirmed to be with arrhythmia of various types and different extents by resting ECG or holter ECG. At the basis of convention therapy, the huangqi and shengmai injection are intended to be administrated to the treatment group while the convention medicines such as Betocloc. Propafenone. lidocaine are administrated to the control group of patients. Result： In contrast to the control group（total effective rate72%） ,the patients from the treatmefit group（total effective rate96%） have got a better improvement of symptoms and the clinical effect of medcines against arrhythmia used in treatment group seems also better than what are used in the control group（P〈0.05）. Conclusion： the huangqi and shengmai injection is effective against moderate arrhythrnia of statistical significance.